Literature DB >> 23642151

Safety issues around misuse of antiepileptics.

Barbara Piskorska1, Barbara Miziak, Stanisław J Czuczwar, Kinga K Borowicz.   

Abstract

INTRODUCTION: Drug misuse is a deliberate or accidental (by omission) nonadherence to medical recommendations, which may range from inappropriate use (missed, increased, or lowered doses or even complete discontinuation of therapy) to compulsive overdosing. Currently, this phenomenon affects as many as 20 - 80% of epileptic patients. AREAS COVERED: Long-standing research has enabled the identification and understanding of factors behind the phenomenon of nonadherence to medical recommendations. An inappropriate use of antiepileptic drugs usually has serious health implications for both children and adults. These involve increased frequency of seizures in patients who lower their doses or discontinue therapy, which may often lead to pathologies. On the other hand, patients who increase or take extra doses expose themselves to toxic effects of antiepileptic drugs. In both cases, there is an increased need for hospitalization, which further implies extra healthcare costs. The most misused antiepileptic drug is gabapentin (53%), whereas the least misused are lamotrigine, levetiracetam, and phenytoin (all drugs at 32%). EXPERT OPINION: The prevalence of misuse of antiepileptic drugs among epileptic patients is comparable to that observed in other chronically ill individuals. Preventive strategies have to be based on the reasons leading to nonadherence.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23642151     DOI: 10.1517/14740338.2013.796363

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

Review 1.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 2.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

3.  A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database.

Authors:  Stefania Chiappini; Fabrizio Schifano
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

4.  Involvement of the dopaminergic system in the reward-related behavior of pregabalin.

Authors:  Yusuf S Althobaiti; Farooq M Almutairi; Fahad S Alshehri; Ebtehal Altowairqi; Aliyah M Marghalani; Amal A Alghorabi; Walaa F Alsanie; Ahmed Gaber; Hashem O Alsaab; Atiah H Almalki; Alqassem Y Hakami; Turki Alkhalifa; Ahmad D Almalki; Ana M G Hardy; Zahoor A Shah
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

5.  A case of pregabalin addiction.

Authors:  Samiksha Sahu; Saurav Kumar; Suprakash Chaudhury; Daniel Saldanha
Journal:  Ind Psychiatry J       Date:  2021-10-22

Review 6.  Epilepsy in Pregnancy-Management Principles and Focus on Valproate.

Authors:  Barbara Błaszczyk; Barbara Miziak; Ryszard Pluta; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.